Biotechnology: Biological Products (No Diagnostic Substances)

Business UpdateNov 11, 2026, 08:02 AM

Recursion Pharmaceuticals to Participate in Upcoming Investor Conferences

AI Summary

Recursion Pharmaceuticals, Inc. (Nasdaq: RXRX), a clinical-stage company focused on AI-enabled drug discovery, announced its participation in three upcoming investor conferences: the Jefferies Global Healthcare Conference, the Evercore 9th Annual Healthcare Conference, and Citi’s 2026 Global Healthcare Conference. Webcasts of these events will be accessible through the company's Investor Relations website.

Key Highlights

Recursion to participate in the Jefferies Global Healthcare Conference in London on November 18, 2026.
Recursion to participate in the Evercore 9th Annual Healthcare Conference on November 30, 2026.
Recursion to participate in Citi’s 2026 Global Healthcare Conference on December 1, 2026.
Webcasts for the conferences will be available on the Recursion Investor Relations website.

View SEC Filing

RXRX

Biotechnology: Biological Products (No Diagnostic Substances)

RECURSION PHARMACEUTICALS, INC.

Price Impact